CAM
SNY icon

Cresset Asset Management’s Sanofi SNY Stock Holding History

Cresset Asset Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,896
Closed -$236K – 1831
2026
Q1 		$236K Buy
+4,896
New +$228K ﹤0.01% 1394
2025
Q2 		– Sell
-5,871
Closed -$326K – 1745
2025
Q1 		$326K Sell
5,871
-187
-3% -$10.1K ﹤0.01% 1268
2024
Q4 		$292K Sell
6,058
-44,579
-88% -$2.27M ﹤0.01% 1364
2024
Q3 		$2.92M Sell
50,637
-1,283
-2% -$69.3K 0.01% 640
2024
Q2 		$2.52M Buy
51,920
+8,307
+19% +$401K 0.01% 623
2024
Q1 		$2.12M Sell
43,613
-1,304
-3% -$63.7K 0.01% 617
2023
Q4 		$2.23M Buy
44,917
+2,417
+6% +$118K 0.01% 544
2023
Q3 		$2.28M Buy
42,500
+8,024
+23% +$428K 0.01% 504
2023
Q2 		$1.86M Buy
+34,476
New +$1.86M ﹤0.01% 665
2022
Q3 		– Sell
-4,680
Closed -$234K – 951
2022
Q2 		$234K Sell
4,680
-1,504
-24% -$79.8K ﹤0.01% 787
2022
Q1 		$318K Buy
6,184
+643
+12% +$33.2K ﹤0.01% 758
2021
Q4 		$277K Sell
5,541
-8,957
-62% -$443K ﹤0.01% 917
2021
Q3 		$699K Buy
14,498
+4,639
+47% +$236K 0.01% 506
2021
Q2 		$519K Buy
9,859
+1,277
+15% +$66.6K 0.01% 539
2021
Q1 		$425K Buy
8,582
+1,991
+30% +$95.7K 0.01% 534
2020
Q4 		$320K Sell
6,591
-927
-12% -$45.7K 0.01% 535
2020
Q3 		$377K Buy
7,518
+1,162
+18% +$59.8K 0.01% 443
2020
Q2 		$324K Sell
6,356
-1,465
-19% -$71.2K 0.01% 436
2020
Q1 		$342K Buy
7,821
+648
+9% +$31K 0.01% 352
2019
Q4 		$360K Buy
7,173
+635
+10% +$29.7K 0.01% 370
2019
Q3 		$303K Buy
+6,538
New +$282K 0.01% 384
2019
Q2 		– Sell
-3,732
Closed -$165K – 1501
2019
Q1 		$165K Buy
3,732
+1,804
+94% +$77.3K 0.01% 422
2018
Q4 		$84K Buy
+1,928
New +$85K 0.01% 367

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Cresset Asset Management's SNY Position: Q2 2026 in Review

Cresset Asset Management sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,896 shares — an estimated $236K sold.

Cresset Asset Management first reported a position in SNY in Q4 2018 and held it in 23 quarters. The position peaked at $2.92M in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cresset Asset Management reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Cresset Asset Management sold 4,896 Sanofi shares in Q2 2026, an estimated $236K.
  • Cresset Asset Management first reported a position in Sanofi in Q4 2018 and held it in 23 quarters.
  • Cresset Asset Management's Sanofi position peaked at $2.92M in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.